Classification of ischemic dysfunctional myocardium combining perfusion quantification and contractile reserve evaluation using nitrate-enhanced gated single photon emission computed tomography with dobutamine test

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 48, Issue 1, 2004, Pages 4-11

  Sciagra R ^a   Leoncini, M ^b   Mennuti, A ^b   Dabizzi, R P ^b   Pupi, A ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MISERICORDIA E DOLCE HOSPITAL   (Italy)

Author keywords

Tomography, emission computed, single photon Myocardial stunning

Indexed keywords

DOBUTAMINE; ISOSORBIDE DINITRATE; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; NITRATE; TRACER;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE CLASSIFICATION; FEMALE; HEART MUSCLE CONTRACTILITY; HEART MUSCLE PERFUSION; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; QUANTITATIVE ANALYSIS; SCAR FORMATION; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE; STUNNED HEART MUSCLE;

ADULT; AGED; AGED, 80 AND OVER; DOBUTAMINE; FEMALE; HUMANS; ISOSORBIDE DINITRATE; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; MYOCARDIAL REVASCULARIZATION; MYOCARDIAL STUNNING; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 4043154321     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989;117: 211-21.
2. Marwick TH. The viable myocardium: epidemiology, detection, and clinical implications. Lancet 1998;351:815-9.
3. Di Carli MF, Davidson M, Little R, Khanna S, Mody FV, Brunken RC et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
4. Pagley PR, Beller GA, Watson DD, Gimple LW, Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:93-800.
5. Bax JJ, Poldermans D, Elhendy A, Cornel JH, Boersma E, Rambaldi R et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
6. Sciagrà R, Pellegri M, Pupi A, Bolognese L, Bisi G, Carnovale V et al. Prognostic implications of Tc-99m Sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 2000;36:739-45.
7. Tillisch J, Brunken R, Marshall R, Schwaiger M, Mandelkern M, Phelps M et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
8. Vanoverschelde JL, Wijns W, Borgers M, Heyndrickx G, Depre C, Flameng W et al. Chronic myocardial hibernation in humans. From bedside to bench. Circulation 1997;95:1961-71.
9. Schulz R, Heusch G. Hibernating myocardium. Heart 2000;84: 587-94.
10. Narula J, Dawson MS, Singh BK, Amanullah A, Acio ER, Chaudhry FA et al. Noninvasive characterization of stunned, hibernating, remodeled and nonviable myocardium in ischemic cardiomyopathy. J Am Coll Cardiol 2000;36:1913-9.
11. Hughes GC, Landolfo CK, Yin B, DeGrado TR, Coleman RE, Landolfo KP et al. Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused? Ann Thorac Surg 2001;72:163-8.
12. Shirani J, Lee J, Quigg R, Pick R, Bacharach SL, Dilsizian V. Relation of thallium uptake to morphologic features of chronic ischemic heart disease: evidence for myocardial remodeling in noninfarcted myocardium. J Am Coll Cardiol 2001;38:84-90.
13. Bax JJ, Visser FC, Poldermans D, Elhendy A, Cornel JH, Boersma E et al. Time course of functional recovery of stunned and hibernating segments after surgical revascularization. Circulation 2001;104: I-314-8.
14. Iskandrian AE, Acio E. Methodology of a novel myocardial viability protocol. J Nucl Cardiol 1998;5:206-9.
15. Bisi G, Sciagrà R, Santoro GM, Fazzini PF. Rest technetium-99m sestamibi tomography in combination with short-term administration of nitrates: feasibility and reliability for prediction of postrevascularization outcome of asynergic territories. J Am Coll Cardiol 1994;24:1282-9.
16. Leoncini M, Marcucci G, Sciagrà R, Frascarelli F, Simonetti I, Bini L et al. Prediction of functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction combining the evaluation of myocardial perfusion and of contractile reserve using nitrate-enhanced technetium-99m sestamibi gated single-photon emission computed tomography and dobutamine stress. Am J Cardiol 2001;87:1346-50.
17. Sciagrà R, Bisi G, Santoro GM, Zerauschek F, Sestini S, Pedenovi P et al. Comparison of baseline-nitrate technetium-99m-sestamibi with rest-redistribution thallium-201 tomography in detecting viable hibernating myocardium and predicting postrevascularization recovery. J Am Coll Cardiol 1997;30:384-91.
18. Chua T, Kiat H, Germano G, Maurer G, van Train K, Friedman J et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability. Correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1107-14.
19. Leoncini M, Marcucci G, Sciagrà R, Frascarelli F, Traini AM, Mondanelli D et al. Nitrate-enhanced gated Tc-99m Sestamibi SPECT for evaluating regional wall motion at baseline and during low dose dobutamine infusion in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison with two-dimensional echocardiography. J Nucl Cardiol 2000;7: 426-31.
20. 201Tl tomography versus dobutamine echocardiography. Circulation 1996; 94:2712-9.
21. Meluzin J, Cerný J, Frélich M, Stetka F, Spinarova L, Popelova J et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1998;32:912-20.
22. Lieberman AN, Weiss JL, Jugdutt BI, Becker LC, Bulkley BH, Garrison JG et al. Two-dimensional echocardiography and infarct size: relationship of regional wall motion and thickening to the extent of myocardial infarction in the dog. Circulation 1981;63: 739-46.
23. Bax JJ, Visser FC, Elhendy A, Poldermans D, Cornel JH, van Lingen A et al. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria. J Nucl Med 1999;40:1866-73.
24. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Circulation 1981;64: 1089-97.
25. Cohn PF, Maddox D, Holman BL, Markis JE, Adams DF, See JR et al. Effect of sublingually administered nitroglycerin on regional myocardial blood flow in patients with coronary artery disease. Am J Cardiol 1977;39:672-8.
26. Fallen EL, Nahmias C, Scheffel A, Coates G, Beanlands R, Garnett ES. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation 1995;91:1381-8.
27. Santoro GM, Bisi G, Sciagrà R, Leoncini M, Fazzini PF, Meldolesi U. Single photon emission computed tomography with technetium-99m hexakis 2-methoxyisobutyl isonitrile in acute myocardial infarction before and after thrombolytic treatment: assessment of salvaged myocardium and prediction of late functional recovery. J Am Coll Cardiol 1990;15:301-14.
28. Sciagrà R, Bolognese L, Rovai D, Sestini S, Santoro GM, Cerisano G et al. Detecting myocardial salvage after primary PTCA: early myocardial contrast echocardiography versus delayed sestamibi perfusion imaging. J Nucl Med 1999;40:363-70.
29. Levine MG, McGill CC, Ahlberg AW, White MP, Giri S, Shareef B et al. Functional assessment with electrocardiographic gated single-photon emission computed tomography improves the ability of technetium-99m sestamibi myocardial perfusion imaging to predict myocardial viability in patients undergoing revascularization. Am J Cardiol 1999;83:1-5.
30. Duncan BH, Ahlberg AW, Levine MG, McGill CC, Mann A, White MP et al. Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability. Am J Cardiol 2000;85:680-4.
31. Stollfuss JC, Haas F, Matsunari I, Neverve J, Nekolla S, Ziegler S et al. 99mTc-tetrofosmin SPECT for prediction of functional recovery defined by MRI in patients with severe left ventricular dysfunction: additional value of gated SPECT. J Nucl Med 1999;40:1824-31.
32. Leoncini M, Marcucci G, Sciagrà R, Frascarelli F, Bellandi F, Gallopin M et al. Usefulness of distinct activity thresholds according to baseline regional asynergy for predicting functional recovery in patients with chronic coronary artery disease and left ventricular dysfunction. A study with nitrate-enhanced Sestamibi gated SPECT. J Nucl Cardiol 2001;8:555-60.
33. Bax JJ, Wijns W, Cornel JH, Visser FC, Boersma E, Fioretti P. Accuracy of the currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data. J Am Coll Cardiol 1997;30:1451-60.
34. Leoncini M, Sciagrà R, Maioli M, Bellandi F, Marcucci G, Sestini S et al. Usefulness of dobutamine Tc-99m sestamibi-gated single-photon emission computed tomography for prediction of left ventricular ejection fraction outcome after coronary revascularization for ischemic cardiomyopathy. Am J Cardiol 2002;89:817-21.